Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиГодовой отчет за 2023 год
добавлен 28.02.2024
CymaBay Therapeutics Мультипликаторы 2011-2024 | CBAY
Мультипликаторы по годам CymaBay Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-32.5 | -8.0 | -2.4 | -7.2 | -1.1 | -6.9 | -15.2 | -1.6 | -1.3 | -3.8 | - | - | - |
P/S |
110.3 | 0.9 | - | - | - | - | 41.9 | - | - | - | - | - | - |
EPS |
-1.0 | -1.2 | -1.3 | -0.7 | -1.5 | -1.2 | -0.8 | -1.1 | -0.8 | -2.6 | 103.5 | -4128.7 | - |
EV (Enterprise Value) |
3.36 млрд | 936 млн | 155 млн | 351 млн | 105 млн | 470 млн | 415 млн | 48.1 млн | 27.9 млн | 133 млн | -10.5 млн | 329 млн | - |
EBITDA per Share |
-0.95 | -1.05 | -1.22 | -0.775 | -1.53 | -1.25 | -0.61 | -1.09 | -1.37 | -1.99 | - | - | - |
EV/EBITDA |
-1634.8 | -6.4 | -0.8 | -6.3 | -18.9 | -1.6 | -0.9 | -4.7 | - | - | - | ||
PEG |
-24.08 | -0.33 | -0.13 | -0.14 | 0.05 | 0.12 | -0.5 | 0.04 | -0.02 | 0.03 | - | - | - |
P/B |
11.7 | 23.5 | 1.6 | 2.6 | 0.6 | 2.9 | 4.9 | 11.0 | 0.7 | 8.7 | - | - | - |
P/CF |
-47.3 | -10.1 | -3.0 | -8.2 | -1.1 | -9.1 | -21.3 | -1.8 | -0.9 | -5.7 | - | - | - |
ROE % |
-36.05 | -293.19 | -67.70 | -35.73 | -55.17 | -42.57 | -32.44 | -677.44 | -55.23 | -230.45 | - | - | - |
ROA % |
-24.24 | -74.73 | -44.48 | -33.15 | -49.97 | -38.85 | -26.43 | -137.77 | -36.05 | -85.17 | - | - | - |
ROCE % |
-34.79 | -257.54 | -65.88 | -37.03 | -54.80 | -42.07 | -24.25 | -254.64 | -70.12 | -141.10 | - | - | - |
Current Ratio |
3.1 | 1.3 | 2.9 | 15.4 | 11.5 | 12.6 | 6.3 | 2.0 | 7.0 | 1.8 | - | - | - |
DSO |
- | - | - | - | - | - | 182.5 | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально CymaBay Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.32 | -0.01 | -0.29 | - | -0.28 | -0.31 | -0.32 | - | -0.33 | -0.34 | -0.25 | - | -0.17 | -0.16 | -0.19 | - | -0.38 | -0.35 | -0.37 | -0.32 | -0.31 | -0.3 | -0.32 | -0.11 | -0.21 | -0.31 | -0.2 | - | -0.25 | -0.3 | -0.29 | - | -0.27 | -0.09 | -0.15 | - | -0.44 | -0.32 | -1.02 | - | 422.95 | -917.59 | -985.06 | - | -637.05 | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.27 | - | -0.24 | -0.27 | -0.28 | - | -0.31 | -0.33 | -0.25 | - | -0.16 | -0.16 | -0.2 | - | -0.4 | -0.37 | -0.39 | - | -0.36 | -0.31 | -0.24 | - | -0.16 | -0.26 | -0.11 | - | -0.24 | -0.27 | -0.29 | - | -0.31 | -0.43 | -0.45 | - | -0.41 | -0.57 | -0.52 | - | -13.2 | -359 | -0.25 | - | -35 | - | - | - | - | - | - |
ROE % |
-79.47 | -109.81 | -141.92 | -99.44 | -125.49 | -110.83 | -99.65 | -61.49 | -69.49 | -51.44 | -37.27 | -24.69 | -38.79 | -44.89 | -50.28 | -39.39 | -50.80 | -47.59 | -44.97 | -42.57 | -37.09 | -35.90 | -36.12 | -32.44 | -175.83 | -315.46 | -482.55 | -500.86 | -521.72 | -393.26 | -220.49 | -33.97 | -77.01 | -99.19 | -117.26 | -138.59 | -145.09 | -108.55 | -97.61 | -32.59 | -32.43 | -25.78 | -13.82 | 0.16 | 0.16 | - | - | - | - | - | - |
ROA % |
-34.99 | -42.86 | -57.75 | -44.47 | -62.93 | -66.00 | -70.59 | -51.14 | -58.56 | -47.53 | -34.66 | -22.91 | -35.68 | -41.03 | -45.74 | -35.68 | -46.09 | -43.26 | -40.96 | -38.85 | -33.27 | -31.23 | -30.41 | -26.43 | -51.97 | -74.43 | -101.99 | -101.86 | -115.47 | -98.72 | -65.75 | -22.17 | -38.08 | -40.37 | -45.68 | -51.22 | -55.24 | -43.36 | -41.73 | -18.95 | -25.24 | -27.52 | -20.68 | -6.30 | -6.30 | - | - | - | - | - | - |
ROCE % |
-71.26 | -96.89 | -125.62 | -87.14 | -112.63 | -102.62 | -95.52 | -61.01 | -69.18 | -51.85 | -37.94 | -25.74 | -40.61 | -47.31 | -53.26 | -41.65 | -54.04 | -51.57 | -48.36 | -30.48 | -38.01 | -33.14 | -31.57 | -19.98 | -163.84 | -300.18 | -452.39 | -480.04 | -503.97 | -384.04 | -246.13 | -71.31 | -111.28 | -127.31 | -145.54 | -118.40 | -125.30 | -92.23 | -62.23 | -31.39 | -31.30 | -24.32 | -12.81 | 0.09 | 0.09 | - | - | - | - | - | - |
Current Ratio |
3.6 | 1.9 | 1.7 | 1.3 | 1.6 | 1.9 | 2.1 | 2.9 | 3.4 | 11.8 | 15.1 | 13.8 | 13.8 | 13.8 | 13.8 | 10.6 | 10.6 | 10.6 | 10.6 | 11.4 | 11.4 | 11.4 | 11.4 | 5.4 | 5.4 | 5.4 | 5.4 | 1.3 | 1.3 | 1.3 | 1.3 | 2.9 | 2.9 | 2.9 | 2.9 | 1.6 | 1.6 | 1.6 | 1.6 | 2.3 | 2.3 | 2.3 | 2.3 | 0.5 | 0.5 | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 87.6 | 95.2 | 95.2 | 47.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 87.6 | 95.2 | 95.2 | 47.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 87.6 | 95.2 | 95.2 | 47.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD